Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women. (ARNO-95)

This study has been completed.
German Adjuvant Breast Cancer Group
Information provided by:
AstraZeneca Identifier:
First received: February 6, 2006
Last updated: June 7, 2009
Last verified: June 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2004
  Estimated Primary Completion Date: No date given